Radio Optimized Vector Engineering platform
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
110
NCT06736418
Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 10, 2025
Completion: Jan 31, 2027
NCT07052760
Imaging of Solid Tumors Using DLL3 SPECT
Phase: Early Phase 1
Role: Collaborator
Start: Nov 30, 2025
Completion: Dec 31, 2027
Loading map...